CSNpharm
CSNpharm
Wedelolactone, a natural compound derived from Chinese herbal medicine Eclipta prostrate L, is an anti-cancer agent for breast and prostate carcinomas in vitro and in vivo targeting multiple cellular proteins including androgen receptors, 5-lipoxygenase and topoisomerase IIα.
More Information
Supplier Page
CSNpharm
Wedelolactone, a natural compound derived from Chinese herbal medicine Eclipta prostrate L, is an anti-cancer agent for breast and prostate carcinomas in vitro and in vivo targeting multiple cellular proteins including androgen receptors, 5-lipoxygenase and topoisomerase IIα.
More Information
Supplier Page
CSNpharm
WHI-P154 is a specific inhibitor of JAK3 with IC50 value of 1.8 μM, almost shows no activity against JAK1 or JAK2.
More Information
Supplier Page
CSNpharm
WHI-P154 is a specific inhibitor of JAK3 with IC50 value of 1.8 μM, almost shows no activity against JAK1 or JAK2.
More Information
Supplier Page
CSNpharm
WHI-P154 is a specific inhibitor of JAK3 with IC50 value of 1.8 μM, almost shows no activity against JAK1 or JAK2.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Wighteone, a natural product isolated and purified from the herbs of Glycyrrhiza glabra, has excellent anti-yeast activity.
More Information
Supplier Page
CSNpharm
Wighteone, a natural product isolated and purified from the herbs of Glycyrrhiza glabra, has excellent anti-yeast activity.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Wogonin acts as an inhibitor of COX2 with IC50 of 46 μM without affecting COX-1 and inhibits the NF-κB pathway-mediated iNOs induction. Wogonin can be isolated from the root of scutellaria baicalensis georgi.
More Information
Supplier Page
CSNpharm
Wogonin acts as an inhibitor of COX2 with IC50 of 46 μM without affecting COX-1 and inhibits the NF-κB pathway-mediated iNOs induction. Wogonin can be isolated from the root of scutellaria baicalensis georgi.
More Information
Supplier Page
CSNpharm
Wogonin acts as an inhibitor of COX2 with IC50 of 46 μM without affecting COX-1 and inhibits the NF-κB pathway-mediated iNOs induction. Wogonin can be isolated from the root of scutellaria baicalensis georgi.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
WS 3
250mg
| ≥95%
CSNpharm
WS-12
10mg
| ≥99%
CSNpharm
WS-12
5mg
| ≥99%
CSNpharm
WS3
10mg
| ≥99%
CSNpharm
WS3 is an Erb3 binding protein-1 (EBP1) and IκB kinase pathway modulator, it’s a non-specific proliferative molecule and promotes β cell proliferation with EC50 of 28 nM.
More Information
Supplier Page
WS3
25mg
| ≥99%
CSNpharm
WS3 is an Erb3 binding protein-1 (EBP1) and IκB kinase pathway modulator, it’s a non-specific proliferative molecule and promotes β cell proliferation with EC50 of 28 nM.
More Information
Supplier Page
WS3
50mg
| ≥99%
CSNpharm
WS3 is an Erb3 binding protein-1 (EBP1) and IκB kinase pathway modulator, it’s a non-specific proliferative molecule and promotes β cell proliferation with EC50 of 28 nM.
More Information
Supplier Page
WS3
100mg
| ≥99%
CSNpharm
WS3 is an Erb3 binding protein-1 (EBP1) and IκB kinase pathway modulator, it’s a non-specific proliferative molecule and promotes β cell proliferation with EC50 of 28 nM.
More Information
Supplier Page
WS6
5mg
| ≥98%
CSNpharm
WS6 is a small molecule that promotes β cell proliferation in rodent and human primary islets with EC50 of 0.28 μM (R7T1 cell viability).
More Information
Supplier Page
WS6
50mg
| ≥98%
CSNpharm
WS6 is a small molecule that promotes β cell proliferation in rodent and human primary islets with EC50 of 0.28 μM (R7T1 cell viability).
More Information
Supplier Page
WS6
10mg
| ≥98%
CSNpharm
WS6 is a small molecule that promotes β cell proliferation in rodent and human primary islets with EC50 of 0.28 μM (R7T1 cell viability).
More Information
Supplier Page
CSNpharm
WST-8 is a water-soluble tetrazolium dye, WST-8 enhances sensitivity of the WST-8-based assay over the conventional MTS-based assay.
More Information
Supplier Page
CSNpharm
WST-8 is a water-soluble tetrazolium dye, WST-8 enhances sensitivity of the WST-8-based assay over the conventional MTS-based assay.
More Information
Supplier Page
CSNpharm
WST-8 is a water-soluble tetrazolium dye, WST-8 enhances sensitivity of the WST-8-based assay over the conventional MTS-based assay.
More Information
Supplier Page
CSNpharm
WST-8 is a water-soluble tetrazolium dye, WST-8 enhances sensitivity of the WST-8-based assay over the conventional MTS-based assay.
More Information
Supplier Page
CSNpharm
Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..
More Information
Supplier Page
CSNpharm
Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..
More Information
Supplier Page
CSNpharm
Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..
More Information
Supplier Page
CSNpharm
Wy-14643 is an agonist of PPARα with EC50 of 0.63 μM that can decrease the inflammatory response. It has other functions including lipid metabolism, cell proliferation, differentiation, adipogenesis etc..
More Information
Supplier Page
CSNpharm
WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K (T389) and mTORC2/P-AKT (S473) not P-AKT (T308), selective for mTOR than PI3Kα (> 100-fold) and PI3Kγ (> 500-fold).
More Information
Supplier Page
CSNpharm
WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K (T389) and mTORC2/P-AKT (S473) not P-AKT (T308), selective for mTOR than PI3Kα (> 100-fold) and PI3Kγ (> 500-fold).
More Information
Supplier Page
CSNpharm
WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K (T389) and mTORC2/P-AKT (S473) not P-AKT (T308), selective for mTOR than PI3Kα (> 100-fold) and PI3Kγ (> 500-fold).
More Information
Supplier Page
CSNpharm
WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K (T389) and mTORC2/P-AKT (S473) not P-AKT (T308), selective for mTOR than PI3Kα (> 100-fold) and PI3Kγ (> 500-fold).
More Information
Supplier Page
WZ811
10mg
| ≥98%
CSNpharm
WZ811
50mg
| ≥98%
CSNpharm